With the Swallowable Gastric BalloonNo Surgery.
No Endoscopy.
No Anesthesia.
Just Results.
The swallowable smart capsule is placed in 15 minutes. A 6-month digital tracking program with expert support for weight management.
*Ienca et al., Obesity Surgery, 2020, n=1,770 (mean TBWL 14.9%). Individual results may vary.
Individual results may vary. Clinical study data represents averages.
*TBWL maintenance rate 1 year after balloon passage (n=522). Source: Caballero A et al., Obes Surg 2025; PMID: 40676353
60+ authorized centers in Türkiye
Not Just a Balloon — A Complete Program
For some patients, a combined weight-management plan with medication may be considered based on physician assessment. Talk to your doctor for details.
Allurion Smart Capsule
- Swallowable — no endoscopy required
- Placed in 15 minutes
- ~16 weeks efficacy duration
- Natural elimination — no removal procedure
- FDA approved, CE marked, TITCK registered
Digital Tracking System
- Allurion mobile application
- Wi-Fi connected smart scale
- Nutrition coach support
- Physician dashboard — real-time data access
- 24/7 support line
Expert & Coaching Support
- Nutrition plan with dietitian
- Behavioral nutrition coach
- Regular clinical follow-up
- Motivation and goal management
- 12-month post-program assessment
How Is the Capsule Placed?
A short overview of the 15-minute procedure
Individual results may vary.
How It Works
Capsule is Swallowed
Swallowed with a glass of water. Confirmed by fluoroscopy, inflated to 550 ml. The entire process takes 15-20 minutes.
Fluoroscopy Verification
The balloon is inflated via a thin catheter and its natural position is confirmed by fluoroscopic imaging.
Natural Passage
Around week 16, the balloon naturally deflates and passes through the digestive system. No second procedure required.
6-Month Digital Follow-up
Mobile app and smart scale data shared in real time with your care team. Dietitian and nutrition coach support throughout.
Global Safety Profile · Allurion 2026 · n=200,000+
Program scope and cost information → Pricing page
Clinical Studies
Ienca et al. — 1,770 Consecutive Patients
Obesity Surgery · 2020 · n = 1,770
19-center multicenter study. Mean TBWL 14.9%, high tolerability confirmed.
PMID: 32279182 · View Study →Individual results may vary.
Allurion + Low-Dose GLP-1 RA
Allurion-Eli Lilly · February 2026 · n = 76
Capsule + GLP-1 receptor agonist. Lean mass ratio increased from 62% to 70%. 100% adherence.
Data on File · Allurion 2026Individual results may vary.
Weight Regain After GLP-1 Discontinuation
EClinicalMedicine (Lancet) · 2025 · n = 3,771, 18 RCTs
Mean +5.63 kg regain when GLP-1 is discontinued. This finding underscores the importance of long-term weight management strategies after pharmacotherapy.
PMID: 41399474 · View Study →Individual results may vary.
Frequently Asked Questions
The capsule is swallowed with a glass of water. Inflated to 550 ml via a thin catheter under fluoroscopic guidance. Process takes 15-20 minutes. No endoscopy, surgery, or anesthesia.
Free Assessment
Let Our Specialists Call You
Let's evaluate together whether it's right for you.